These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15821333)

  • 1. [Clinical aspects of treatment of genital herpes with plaferon LB and phenowine].
    Nozadze TG; Korsantiia NB; Kupradze SA
    Georgian Med News; 2005 Jan; (118):67-70. PubMed ID: 15821333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
    Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valacyclovir for the treatment of genital herpes.
    Brantley JS; Hicks L; Sra K; Tyring SK
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):367-76. PubMed ID: 16771614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
    Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
    Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
    Handsfield HH; Warren T; Werner M; Phillips JA
    Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of acyclovir in the treatment of recurring herpes labialis, genitalis and acute herpes zoster.
    Peralta S; Ribisi La Spina AM; Pirrotta P; Collura D; Formica P; Tinnirello D; Citarrella P; Mansueto S
    J Chemother; 1989 Jul; 1(4 Suppl):1117-8. PubMed ID: 16312797
    [No Abstract]   [Full Text] [Related]  

  • 8. [Local treatments using antiviral and non-antiviral drugs for herpes facialis and genitalis (excluding pregnant females and neonates at risk)].
    Chosidow O; Lebrun-Vignes B
    Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):635-45. PubMed ID: 12122334
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of testosterone preparations in complex therapy of severe herpetic keratitis in male patients].
    Zaĭnutdinova GKh; Mal'khanov VB
    Vestn Oftalmol; 2004; 120(3):24-6. PubMed ID: 15216768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment with acyclovir combined with a new Romanian product from plants].
    Corina P; Dimitris S; Emanuil T; Nora R
    Oftalmologia; 1999; 46(1):55-7. PubMed ID: 10641087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment to: topical honey application vs. acyclovir for the treatment of recurrent herpes simplex lesions Al-Waili NS Med Sci Monit, 2004; 10(8): MT94-MT98.
    Carilli S
    Med Sci Monit; 2005 Dec; 11(12):LE24. PubMed ID: 16319801
    [No Abstract]   [Full Text] [Related]  

  • 12. Testing of the in vivo therapeutic efficacy on the cutaneous herpes simplex infections of the autochthonous product 5% Acyclovir ointment.
    Crişan I; Rojanschi D; Petica M; Fodor C; Morar S; Muţiu A
    Rom J Virol; 1996; 47(1-4):13-24. PubMed ID: 9495780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of oral acyclovir and imiquimod for the treatment of hypertrophic genital herpes simplex in HIV positive patients: report of two cases.
    Barbosa Ldo N; Souto R; Furtado AL; Gripp AC; Daxbacher E
    An Bras Dermatol; 2011; 86(5):1043-5. PubMed ID: 22147057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Audit of the management of genital herpes simplex infection.
    Matin RN; Brady M; Poulton M
    Int J STD AIDS; 2006 Dec; 17(12):851-3. PubMed ID: 17212865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunomodulating dipeptide, SCV-07, is a potential therapeutic for recurrent genital herpes simplex virus type 2 (HSV-2).
    Rose WA; Tuthill C; Pyles RB
    Int J Antimicrob Agents; 2008 Sep; 32(3):262-6. PubMed ID: 18619817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plaferon lb as a protector of radioinducible disorder].
    Saralidze MA; Datunashvili IV; Machavariani MG; Enukidze MG; Pavliashvili AT
    Georgian Med News; 2005 Dec; (129):110-2. PubMed ID: 16444047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guidelines (brief text): management of cutaneo-mucosal herpes in the immunocompetent patient (ocular manifestations excluded)].
    J Gynecol Obstet Biol Reprod (Paris); 2003 Feb; 32(1):58-67. PubMed ID: 12592186
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical honey application vs. acyclovir for the treatment of recurrent herpes simplex lesions.
    Al-Waili NS
    Med Sci Monit; 2004 Aug; 10(8):MT94-8. PubMed ID: 15278008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro.
    Nolkemper S; Reichling J; Stintzing FC; Carle R; Schnitzler P
    Planta Med; 2006 Dec; 72(15):1378-82. PubMed ID: 17091431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of one year of episodic or suppressive treatment of recurrent genital herpes with valacyclovir.
    Fife KH; Almekinder J; Ofner S
    Sex Transm Dis; 2007 May; 34(5):297-301. PubMed ID: 16960547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.